dm+d
Unassigned
New Medicines
Moderate to severe chronic obstructive pulmonary disease (COPD) in adults
Information
New molecular entity
Chiesi
Chiesi
Development and Regulatory status
None
Phase III Clinical Trials
None
Category
Phosphodiesterase 4 inhibitor
An estimated 1.2 million people are affected by COPD in the UK. There are 115,000 new diagnoses a year. Nevertheless, COPD remains underdiagnosed. 60-85% of patients, mainly with mild-to-moderate disease, are thought to remain undiagnosed [1].
Moderate to severe chronic obstructive pulmonary disease (COPD) in adults
Inhalation